Literature DB >> 9880801

Promotion of tyrosinase folding in COS 7 cells by calnexin.

K Toyofuku1, I Wada, K Hirosaki, J S Park, Y Hori, K Jimbow.   

Abstract

To understand the process of expression of tyrosinase, a key enzyme of melanogenesis, we examined its maturation in the endoplasmic reticulum (ER) by using a heterogeneous expression system. When human tyrosinase cDNA was introduced into COS 7 cells, tyrosinase activity was minimally detected. Immunofluorescence study revealed that tyrosinase was immunolocalized in the nuclear rim, the reticular network, and the punctuated structures. Because a cytoplasmic tail of tyrosinase-gene family protein functions as a lysosomal targeting signal in non-melanocytic cells, and immature and/or misfolded molecules are selectively retained in the ER, the observed localization suggested the inefficient maturation in the COS 7 cells. We thus examined if supplementation of calnexin, a membrane-bound chaperone with affinity for oligosaccharide-processing intermediates containing monoglucose, could improve the process. As expected, the activity was enhanced approximately 2-fold by co-transfection of cDNA encoding calnexin. In contrast, co-transfection of the cytosolic tail-free calnexin, which inhibits calnexin function by allowing premature egress of its ligands from the ER, suppressed expression of this enhanced tyrosinase activity. When alpha-glucosidase activity, which is required for calnexin function, was inhibited by castanospermine (CST) treatment, expression of tyrosinase activity was completely abolished. To confirm the direct involvement of calnexin in tyrosinase maturation, the interaction of calnexin with tyrosinase was examined. Immunoprecipitation of calnexin from extracts of [35S]methionine labeled cells with anti-calnexin antibody revealed that the association is highest immediately after the pulse and that nascent tyrosinase is gradually dissociated upon chase. The association was completely inhibited when CST was included in the medium. Hence, we suggest that the proper folding of tyrosinase is largely dependent on its direct interaction with calnexin for the determined duration in the ER.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9880801     DOI: 10.1093/oxfordjournals.jbchem.a022272

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  9 in total

1.  The molecular basis of oculocutaneous albinism type 1 (OCA1): sorting failure and degradation of mutant tyrosinases results in a lack of pigmentation.

Authors:  K Toyofuku; I Wada; R A Spritz; V J Hearing
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

2.  Pink-eyed dilution protein controls the processing of tyrosinase.

Authors:  Kun Chen; Prashiela Manga; Seth J Orlow
Journal:  Mol Biol Cell       Date:  2002-06       Impact factor: 4.138

3.  Endoplasmic reticulum retention is a common defect associated with tyrosinase-negative albinism.

Authors:  R Halaban; S Svedine; E Cheng; Y Smicun; R Aron; D N Hebert
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 4.  Role of N-oligosaccharide endoplasmic reticulum processing reactions in glycoprotein folding and degradation.

Authors:  A J Parodi
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

Review 5.  Tyrosinase-expressing neuronal cell line as in vitro model of Parkinson's disease.

Authors:  Takafumi Hasegawa
Journal:  Int J Mol Sci       Date:  2010-03-12       Impact factor: 5.923

6.  Apical targeting and Golgi retention signals reside within a 9-amino acid sequence in the copper-ATPase, ATP7B.

Authors:  Lelita Braiterman; Lydia Nyasae; Yan Guo; Rodrigo Bustos; Svetlana Lutsenko; Ann Hubbard
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-11-25       Impact factor: 4.052

Review 7.  N-Glycan-based ER Molecular Chaperone and Protein Quality Control System: The Calnexin Binding Cycle.

Authors:  Lydia Lamriben; Jill B Graham; Benjamin M Adams; Daniel N Hebert
Journal:  Traffic       Date:  2016-01-10       Impact factor: 6.215

8.  Melanoma-Targeted Chemothermotherapy and In Situ Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite Nanoparticles.

Authors:  Kowichi Jimbow; Yasue Ishii-Osai; Shosuke Ito; Yasuaki Tamura; Akira Ito; Akihiro Yoneta; Takafumi Kamiya; Toshiharu Yamashita; Hiroyuki Honda; Kazumasa Wakamatsu; Katsutoshi Murase; Satoshi Nohara; Eiichi Nakayama; Takeo Hasegawa; Itsuo Yamamoto; Takeshi Kobayashi
Journal:  J Skin Cancer       Date:  2013-02-21

Review 9.  Elucidation of Melanogenesis Cascade for Identifying Pathophysiology and Therapeutic Approach of Pigmentary Disorders and Melanoma.

Authors:  Tokimasa Hida; Takafumi Kamiya; Akinori Kawakami; Jiro Ogino; Hitoshi Sohma; Hisashi Uhara; Kowichi Jimbow
Journal:  Int J Mol Sci       Date:  2020-08-25       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.